Ionis Pharmaceuticals Inc
Company Profile
Business description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Contact
2855 Gazelle Court
Carlsbad CA 92010
USAT: +1 760 931-9200
E: WWalke@ionisph.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
927
Ionis Pharmaceuticals Inc News & Analysis
stocks
Global healthcare stocks for your watchlist
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,247.00 | 15.40 | -0.19% |
| CAC 40 | 7,632.71 | 91.61 | -1.19% |
| DAX 40 | 18,590.89 | 157.29 | -0.84% |
| Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
| FTSE 100 | 8,182.96 | 69.95 | -0.85% |
| HKSE | 17,785.87 | 230.07 | -1.28% |
| NASDAQ | 18,472.57 | 74.12 | 0.40% |
| Nikkei 225 | 41,288.93 | 98.25 | 0.24% |
| NZX 50 Index | 12,184.49 | 61.35 | 0.51% |
| S&P 500 | 5,631.22 | 15.87 | 0.28% |
| S&P/ASX 200 | 8,002.80 | 14.80 | -0.18% |
| SSE Composite Index | 2,973.02 | 0.99 | -0.03% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Droneshield Ltd DRO | 2.02 | 0.58 | -22.31% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.94% |
| Red 5 Ltd RED | 0.42 | 0.00 | 0.00% |
| Mirvac Group MGR | 2.12 | 0.04 | 1.92% |
| Imugene Ltd IMU | 0.06 | 0.00 | -3.51% |
| Telstra Group Ltd TLS | 3.83 | 0.01 | -0.26% |
| Bellevue Gold Ltd BGL | 1.87 | 0.07 | -3.37% |
| Latin Resources Ltd LRS | 0.16 | 0.01 | -5.88% |
| Zip Co Ltd ZIP | 1.61 | 0.03 | 1.90% |
| Australian Vanadium Ltd AVL | 0.02 | 0.00 | 6.25% |